Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Fluticasone furoate
Drug ID BADD_D00946
Description Fluticasone furoate is a synthetic glucocorticoid available as an inhaler and nasal spray for various inflammatory indications[FDA Label][F4364]. Fluticasone furoate was first approved in 2007[L5965].
Indications and Usage Fluticasone furoate is indicated as an inhaler for the treatment and management of asthma by prophylaxis[FDA Label][F4364]. The fluticasone furoate nasal spray is indicated for treating season and perennial allergic rhinitis[FDA Label][A177130].
Marketing Status approved
ATC Code R01AD12; R03BA09
DrugBank ID DB08906
KEGG ID D06315
MeSH ID C523187
PubChem ID 9854489
TTD Drug ID D0Y7JU
NDC Product Code 47848-057; 64918-1915; 0135-0615; 64918-1910; 64918-1916; 22552-0042; 63379-083; 55018-302; 58175-0553; 0135-0616; 63592-3370; 0173-0874; 0173-0888; 50090-5967; 49076-6452; 59057-010; 0173-0876; 50090-6075; 15308-2021; 52482-008; 63379-084; 49076-6451; 59057-009; 64918-1117
UNII JS86977WNV
Synonyms fluticasone furoate
Chemical Information
Molecular Formula C27H29F3O6S
CAS Registry Number 397864-44-7
SMILES CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)OC(=O)C5=CC=CO5)C)O)F)C)F
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Cerebral haemorrhage24.07.04.001; 17.08.01.003--Not Available
Cerebrovascular accident17.08.01.007; 24.03.05.001--
Chest discomfort02.02.02.009; 22.12.02.002; 08.01.08.019--Not Available
Choking22.12.03.003--Not Available
Chronic obstructive pulmonary disease22.03.01.007--Not Available
Condition aggravated08.01.03.0040.000611%Not Available
Conjunctivitis11.01.06.012; 06.04.01.002--
Cough22.02.03.001--
Cushing's syndrome24.08.04.001; 19.07.03.002; 14.11.01.007; 05.01.01.0010.001528%Not Available
Deafness04.02.01.001--Not Available
Death08.04.01.001--
Dementia19.20.02.001; 17.03.01.001--Not Available
Dermatitis23.03.04.002--Not Available
Diabetes mellitus14.06.01.001; 05.06.01.001--Not Available
Diarrhoea07.02.01.001--
Dizziness02.11.04.006; 24.06.02.007; 17.02.05.0030.001956%
Drug eruption23.03.05.001; 10.01.01.005; 08.01.06.0150.000917%Not Available
Drug ineffective08.06.01.0060.006540%Not Available
Dry mouth07.06.01.002--
Dry throat22.12.03.005; 07.06.01.005--Not Available
Dysgeusia07.14.03.001; 17.02.07.003--
Dysphonia22.12.03.006; 19.19.03.002; 17.02.08.004--
Dyspnoea02.11.05.003; 22.02.01.0040.003301%
Emphysema22.01.02.002--Not Available
Epistaxis22.04.03.001; 24.07.01.0050.002384%
Eye disorder06.08.03.001--Not Available
Fatigue08.01.01.0020.000611%
Fear19.06.03.001--Not Available
Fluid retention20.01.02.003; 14.05.06.002--Not Available
Glaucoma06.03.01.002--
The 2th Page    First    Pre   2 3 4 5 6    Next   Last    Total 6 Pages